Immunotherapy in Corticotroph and Lactotroph Aggressive Tumors and Carcinomas: Two Case Reports and a Review of the Literature

Once temozolomide has failed, no other treatment is recommended for pituitary carcinomas and aggressive pituitary tumors. Recently, the use of immune checkpoint inhibitors (ICIs) has raised hope, but so far, only one corticotroph carcinoma and one aggressive corticotroph tumor treated with immunothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Duhamel, Camille, Ilie, Mirela Diana, Salle, Henri, Nassouri, Adjoa Sika, Gaillard, Stephan, Deluche, Elise, Assaker, Richard, Mortier, Laurent, Cortet, Christine, Raverot, Gérald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563495/
https://www.ncbi.nlm.nih.gov/pubmed/32823651
http://dx.doi.org/10.3390/jpm10030088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563495/
https://www.ncbi.nlm.nih.gov/pubmed/32823651
http://dx.doi.org/10.3390/jpm10030088

Ejemplares similares